Results 191 to 200 of about 5,166 (218)

First identification and molecular characterization of CTX-M-15 extended-spectrum β-lactamase and OXA-9 β-lactamase in <i>Haemophilus influenzae</i> in the Iberian Peninsula. [PDF]

Antimicrob Agents Chemother
González-Díaz A, Pinto M, Cadenas-Jiménez I, Duarte S, Ardanuy C, Ribeiro MM, Martí S, Bajanca-Lavado P.   +7 more
europepmc   +1 more source

Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinants. [PDF]

Antimicrob Agents Chemother
Báez-Barroso G-A, Rodríguez-Coello A, Vázquez-Ucha JC, López-Argüello S, Outeda-García M, González-Pinto L, García-Pose A, Guijarro-Sánchez P, Alonso-García I, Lence E, González-Bello C, Oliver A, Arca-Suárez J, Moya B, Bou G, Beceiro A, Spanish National Acinetobacter spp. 2020 Study Group.   +16 more
europepmc   +1 more source

Characterization of <i>Enterobacter cloacae complex</i> clinical isolates: comparative genomics and the role of the efflux pump AcrAB-TolC over-expression and NDM-1 production. [PDF]

Front Cell Infect Microbiol
Jiang N, Pu F, Wang W, Wang D, He J.
europepmc   +1 more source

Cefepime Combined with Late-Generation β-Lactamase Inhibitors: Mechanisms of Action, In Vitro Activity, PK/PD Characteristics, Clinical Evidence and Resistance Mechanisms. [PDF]

Antibiotics (Basel)
Comini S, Boattini M, Gaibani P, Bianco G.   +3 more
europepmc   +1 more source

Synthesis, Characterization, and Biological Evaluation of Novel Azo-Based Imidazo[1,2‑<i>a</i>]pyridine Derivatives: In Vitro and In Silico Investigations. [PDF]

ACS Omega
Azzouzi M, El Hadad SE, Ikken N, Fait S, Ndjogo MM, Chaoui Roqai M, Timinouni M, Daoud R, Oussaid A.   +8 more
europepmc   +1 more source

Genetic basis of cefiderocol resistance in <i>Acinetobacter baumannii</i>: insights from functional genomics and clinical isolates. [PDF]

Microbiol Spectr
Rome KJ, Mediavilla JR, Terlecky AJ, Bucich MJ, Shashkina E, Jiang J, Kunkle D, Rojtman A, Skaar E, Chen L, Kreiswith BN.   +10 more
europepmc   +1 more source

Decreased susceptibility to cefepime/zidebactam among carbapenemase-producing Escherichia coli from Stockholm, Sweden with alterations in PBP2. [PDF]

J Antimicrob Chemother
Tellapragada C, Dunleavy C, Jonsson P, Giske CG.   +3 more
europepmc   +1 more source

A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of <i>Acinetobacter</i> spp. [PDF]

Antimicrob Agents Chemother
Veeraraghavan B, Shin E, Bakthavatchalam YD, Manesh A, Dubey D, Tascini C, Taracila MA, Hujer AM, Jacobs MR, Bonomo RA.   +9 more
europepmc   +1 more source